Daily as of 3 Nov 16:00 ET
- Price
- below both $8.96 vs 50 $19.13 / 200 $21.12
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 21 Oct 2026 · projected 29 bars out
BCAX | Bicara TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$8.96
+$1.03 (+12.99%)
Bicara Therapeutics (BCAX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- below both $8.96 vs 50 $15.79 / 200 $22.77
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 14 Sep 2026 · projected 30 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 21 Oct 2026 | 💀Death steep | daily | 29 bars out | Not tested |
| 14 Sep 2026 | 💀Death | 4-hour | 30 bars out | Not tested |
| 13 Oct 2025 | 🟨Golden steep | daily | 12 bars out | Not tested |
About BCAX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$13.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandsmall